Sanofi to launch spinout that could compete with Asia-sourced APIs

In a move that could help decrease industry reliance on APIs from Asia, Sanofi revealed plans to spin off its API business, which will be headquartered in France.

The newco will house the pharma’s API commercial and development activities as well as six of Sanofi’s European API production sites including sites in Italy, Germany, U.K., France and Hungary, a commercial network covering 80 countries and a portfolio of around 200 APIs. Sanofi (Euronext:SAN; NASDAQ:SNY) said it will remain an “important customer” of the spinout. ...